CVS Health (NYSE:CVS) shares extended six straight sessions of losses, as the stock slipped 0.7% at $63.38 on Thursday. The ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

This was the stock's eighth consecutive day of losses.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.

CVS Health is expected to release its fiscal second-quarter earnings later this month, and analysts project a double-digit profit drop.

CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement ...

The lawsuit was filed under the False Claims Act, which helps the government combat fraud and requires tripling of damages, ...

A federal judge ordered CVS Health's Omnicare unit to pay $948.8 million in penalties and damages, in a whistleblower lawsuit ...

CVS Health’s revenue of $89.8 billion in Q3 was up 11% y-o-y, with sales growth across all segments. Looking at segments, Health Care Benefits sales increased by 17%, Health Services sales were ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...